The Jaklenec Research Lab at the MIT Koch Institute for Integrative Cancer Research works at the interface of engineering and immunology with a focus on global health. The lab develops innovative and translatable technologies to help large populations globally, especially in developing countries.
Recent News
Treatment Harnesses Light to Target Cancer
June 12, 2025
When exposed to a near-infrared laser, injected microparticles release heat and chemotherapy directly to the tumor…
Manuscript Published in Advanced Healthcare Materials
June 11, 2025
This review examines current and emerging oral delivery platforms designed to overcome these barriers and enhance nutraceutical efficacy….
No more second shots: a step towards self-boosting vaccines
June 6, 2025
MIT Scientists are designing microparticles that could deliver vaccines at predefined times after they’ve been injected…